Aaron Pearce
Analyst · Bank of America Merrill Lynch
Thank you, Michael, and good morning, everyone. The financial review starts on Slide number 3. Sales decreased 1.9% to $282.4 million in the second quarter; which consisted of organic sales growth of 2.3%, a decrease of 2.6% from foreign currency translation, and a reduction of 1.6% from the sale of our Runelandhs business which was finalized in the fourth quarter of last fiscal year, We increased pretax earnings by 4.8% when compared to the second quarter of last year. Looking at after-tax earnings, we finished at $29.2 million which was up substantially compared to last year's earnings of $4.3 million. In last year's second quarter, we took a tax charge of $21.1 million related to the U.S. tax legislation passed by Congress in December of 2017. Without this tax charge, our prior year net earnings would have been $25.4 million. Diluted earnings per share was $0.55 this quarter compared to diluted EPS of $0.08 in last year's second quarter. The income tax charge that I just mentioned reduced EPS by approximately $0.40 last year. Without this charge, our prior year second quarter EPS would have been $0.48. Cash flow from operating activities was $25.4 million this quarter compared to $7.7 million in last year's second quarter and free cash flow was $19.3 million compared to $3 million in last year's second quarter. Much of this improvement is a result of the timing of our annual incentive compensation payments. Moving along to Slide number 4, you'll find our quarterly sales trends. Organic sales growth was driven by our IDS business while we realized a slight decline in WPS organic sales due to the performance of our North American business. Our gross profit margin trending is summarized on Slide number 5. Our gross profit margin finished at 49.5% this quarter, which is down 40 basis points from last year's second quarter gross profit margin of 49.9%. This decline was due to an increase in certain costs, including freight and labor in both our IDS and WPS businesses, We've been able to partially offset increased costs in our IDS business with increased volume, selective price increases, and ongoing efficiency gains. In our WPS business, we've also focused heavily on efficiency gains and cost controls, but it hasn't been enough to fully offset input cost increases. We continue to drive efficiency gains across all of our businesses and increased prices where feasible, which we expect will offset the majority of input cost increases and enable us to maintain a strong gross profit margin in future quarters. Moving along to Slide number 6, you'll find our SG&A expense trending. SG&A was $92.7 million this quarter compared to $97.6 million in last year's second quarter. The decrease was due to a combination of foreign currency translation, reduced SG&A from the sale of our Runelandhs business, and our ongoing efficiency activities. As a percentage of sales, SG&A expense decreased from 33.9% in the second quarter of last year to 32.8% this quarter. Turning to Slide number 7, you'll find the trending of our investments in research and development, which decreased from $11.3 million in the second quarter of last year to $11.1 million this quarter. Year-to-date R&D expenses are up 2.6% and we expect to finish the year with R&D expense up around 6% for the full fiscal year ending July 31 as we continue to increase our investment in the development of new products. Slide number 8 is the quarterly trending of pretax earnings where we've experienced year-on-year growth in each quarter for more than 3 years. This quarter we increased pretax earnings by 4.8% finishing at $36.7 million compared to $35 million in the second quarter of last year. Moving to Slide number 9, you'll find the trending of quarterly earnings per share and net earnings. As I mentioned, in last year's second quarter we recognized additional income tax expense equal to approximately $0.40 of EPS from the enactment of the US tax reform. If you exclude this item, our diluted EPS increased from $0.48 in last year's second quarter to $0.55 this quarter. Slide number 10 details our quarterly cash generation. We generated $25.4 million of cash flow from operating activities compared to $7.7 million in last year's second quarter and free cash flow was $19.3 million compared to $3 million in the same quarter of last year. The increase in cash generation in the second quarter was due to our improved earnings along with a change in the timing of our annual incentive compensation payments to employees. Last year, all of these payments were made in the second quarter whereas this year, the payments were split between the first and second quarters. So the best way to look at our cash flow performance is to remove this timing noise by simply looking at our year-to-date cash flow from operating activities, which was up 4.1%. This quarter we used our cash to invest in the organic business and to return funds to our shareholders in the form of dividends as well as a modest amount of share repurchases. Turning to Slide number 11. This chart outlines the trending of our net cash position as well as a snapshot of our debt structure at the end of the quarter. We increased our net cash position by $12.8 million this quarter and finished in a net cash position of $150.6 million at January 31. Our debt consists of a €45 million private placement scheduled for payment in May of 2020 and we have no borrowings outstanding on our $300 million line of credit. Our approach to capital allocation is consistent, we are disciplined and we're patient. First, we use our cash to fund organic sales and efficiency opportunities throughout the economic cycle, which includes funding investments in new product development, sales generating resources, IT improvements, capability enhancing capital expenditures, and capital expenditures to increase efficiency and automation in our factories. And second, we focus on returning cash to our shareholders in the form of dividends. After funding organic investments and dividends, we then patiently deploy our capital in a disciplined manner for acquisitions where we believe we have strong synergistic opportunities and we use our cash to improve shareholder returns through opportunistic share repurchases. We have approximately 1.9 million shares authorized for repurchase as of January 31. Overall, our cash generation is strong, our balance sheet is strong, and we're focused on driving long-term value for our shareholders through the disciplined allocation of capital. Slide number 12 summarizes our fiscal 2019 guidance. We're increasing our full-year EPS guidance from a range of $2.20 to $2.30 per share to our new range of $2.25 to $2.35 per share. Our increased guidance range is primarily due to the lower than originally anticipated full-year income tax rate, which is now expected to be between 22% and 24%. This guidance is based on foreign currency exchange rates as of January 31, which is a headwind due to the strengthening of the US dollar. We also expect organic sales growth to be at the lower end of our previously provided range of 3% to 5% for the full fiscal year ending July 31, 2019. Included in this guidance is an increase in our R&D expense of approximately 6%, depreciation and amortization expense of approximately $26 million, and capital expenditures ranging from $30 million to $35 million. Included in our CapEx guidance is approximately $10 million of expenditures related to the construction of certain facilities that are currently leased. Excluding this incremental CapEx for facility construction cost, we're still running a bit higher than our historical average due to the increased investments we're making in automation and manufacturing capabilities, which are meant to drive efficiency gains and increase our capabilities. Lastly, we're not anticipating any restructuring charges and we're not excluding any one-time items from this guidance. I'll now turn the call back over to Michael to cover our divisional results. Michael?